U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06855264) titled 'A Cardiac Liability Study of Varegacestat in Healthy Participants' on Feb. 25.
Brief Summary: This clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: varegacestat
Single oral dose of varegacestat
DRUG: Placebo
Single oral dose of placebo
DRUG: Moxifloxacin 400 mg
Single oral dose of moxifloxacin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Immunome, Inc.
Published by HT Digital Content Services with permission from Health Daily D...